Dr. Lal PathLabs Ltd has set Dec 19, 2025, as the record date for its 1:1 bonus. This means that every eligible shareholder will be receiving 1 free share for every share held.
Dr. Lal PathLabs Ltd said in an exchange filing, “The Members of the Company approved issuing bonus equity shares, in the proportion of 1:1 i.e., One (1) new fully paid-up equity share of face value of INR 10/- (Rupee Ten Only) each for every One (1) existing fully paid-up equity share of face value of INR 10/- (Rupee Ten Only) each to the eligible Members of the Company.”
In this regard, we wish to inform you that the Board of Directors today i.e. December 12, 2025, through Circular Resolution fixed “Friday, December 19, 2025” as the Record Date for the purpose of determining the eligibility of the Members of the Company for issuing bonus equity shares
As Dr. Lal PathLabs has set Dec 19 as the record date for the bonus issue, meaning that Dec 18 is the last day to buy Dr. Lal PathLabs shares to become eligible for the bonus issue. Further, any shares bought on or after Dec 19 (record date), won't be eligible for the bonus shares due to the T+1 settlement rule. Shareholders must hold shares in a valid demat account as of the record date to be eligible for the bonus issue.
Also Read: Canara Robeco AMC Declares ₹1.50 Interim Dividend on December 16
Dr Lal PathLabs is a leading provider of diagnostic and related healthcare tests and services in India, offering a comprehensive range of solutions for disease diagnosis, prevention, monitoring, and treatment through its integrated nationwide network. As of March 31, 2025, the company operates 298 clinical laboratories, including a National Reference Laboratory in Delhi and Regional Reference Laboratories in Kolkata, Bangalore, and Mumbai, along with 6,607 Patient Service Centers and 12,365 Pick-up Points across the country. Its customer base includes individual patients, hospitals, healthcare providers, and corporate clients.
The company delivered strong financial performance, with revenue growth of 10.7% in Q2FY26 and 11.0% in 1HFY26, EBITDA growth of 10.8% with a margin of 30.7%, and PAT growth of 16.4% with a margin of 20.8%. Additionally, the company declared an interim dividend of ₹7 per share for Q2FY26 and approved a bonus issue in the ratio of 1:1, granting one bonus share for every share held as of the record date.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Dec 18, 2025, 8:59 AM IST
Sachin Gupta
Sachin Gupta is a Content Writer with 6+ years of experience in the stock market, including global markets like the US, Canada, and Australia. At Angel One, Sachin specialises in creating financial content that simplifies complex market trends. Sachin holds a Master's in Commerce, specialising in Economics.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
